HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Irreversible cochlear damage in myasthenia gravis -- otoacoustic emission analysis.

AbstractOBJECTIVE:
Acetyl choline (ACh) is the main neurotransmitter of the efferent auditory system. This study is aimed to evaluate cochlear function in myasthenia gravis (MG), a neuromuscular transmission disorder caused by ACh receptor autoantibodies.
METHODS:
This prospective study included 16 myasthenic patients, tested audiologically twice, first after improvement from myasthenic crisis or acute oropharyngeal dysfunction (1 week from admission) and then 2 months later. We detected the effect of contralateral acoustic stimulation (CAS) on patients' transient and distortion product otoacoustic emissions (TEOAE and DPOAE).
RESULTS:
Compared with controls, patients reported significant reduction in overall echo response and amplitude of TEOAEs at 1-2 kHz and at 1-6 kHz of DPOAE with marked reduction at 5 kHz. In the control group, CAS produced amplitude reduction in TEOAEs and DPOAEs at 1-4 kHz. Utilizing masking effect, patients reported amplitude reduction in TEOAEs at 1.5-4 kHz while DPOAEs did not reach significant level except at 1.5 and 5 kHz. After 2 months, no changes were observed compared with early assessment.
CONCLUSIONS:
It is clear that disease progression is associated with irreversible cochlear damage. Lack of improvement in patients' emissions despite partial non-audiometric improvement in relation to receptors needs to be considered.
AuthorsS A Hamed, A M Elattar, E A Hamed
JournalActa neurologica Scandinavica (Acta Neurol Scand) Vol. 113 Issue 1 Pg. 46-54 (Jan 2006) ISSN: 0001-6314 [Print] Denmark
PMID16367899 (Publication Type: Controlled Clinical Trial, Journal Article)
Topics
  • Adolescent
  • Adult
  • Auditory Threshold
  • Chronic Disease
  • Cochlea (pathology, physiopathology)
  • Diagnostic Techniques, Otological
  • Female
  • Follow-Up Studies
  • Hearing Loss, Sensorineural (diagnosis, etiology, physiopathology)
  • Humans
  • Male
  • Middle Aged
  • Myasthenia Gravis (complications, physiopathology)
  • Otoacoustic Emissions, Spontaneous
  • Prospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: